. . . . . . . . . "ABSTRALĀ® is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving, and who are tolerant to, around-the-clock opioid therapy for their underlying persistent cancer pain." . . . . . . "in cancer patients 18 years of age and older" . "18" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "GFGdoa+Dvg/NF7sXwCdUcm6zr8PznjOXsWnIcOEvPYMO+uKt1ClF4U4POL73DDf9/DZ/DIi1ZpqvCZVEOYbT71sfsFzP6lGfFvGgGZZElHIRz+hm4ONxwmKPkBcNrMgGLaA1kOVslvKUa+gqBQr43Q4GMCwyL4ZQFJr6hcQMW34=" . . "2021-04-12T09:15:24.446+02:00"^^ . . . . .